## ISRG: Intuitive Surgical, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 -0.8% below STRENGTH zone (3.0-6.0%); PEG 2.79 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($550.44)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Invesco Ltd. Grows Stock Holdings in Intuitive Surgical, Inc. $ISRG**
- Source: MarketBeat | 20251204T083705 | Bullish | Relevance: 99%
-  Invesco Ltd. increased its stake in Intuitive Surgical, Inc. by 4.8% during the second quarter, bringing its total holdings to 4,421,133 shares worth approximately $2.40 billion, making it their 27th largest holding. Despite this, company insiders have been net sellers, divesting over $60 million in shares in the past 90 days. Analysts maintain a "Moderate Buy" rating for Intuitive Surgical, which recently surpassed quarterly earnings and revenue estimates.

**2. If You Invested $1000 in Intuitive Surgical, Inc. a Decade Ago, This is How Much It'd Be Worth Now**
- Source: MSN | 20251204T080920 | Bullish | Relevance: 99%
-  This article calculates the hypothetical return on a $1,000 investment in Intuitive Surgical, Inc. made ten years ago, providing insights into its current value. It highlights the significant growth experienced by the company's stock over the past decade. This information can be useful for investors interested in long-term performance analysis of medical technology stocks.

**3. Intuitive Surgical (ISRG): Revisiting Valuation After a 25% Three-Month Share Price Rally**
- Source: Simply Wall Street | 20251204T085944 | Somewhat-Bullish | Relevance: 98%
- Intuitive Surgical (ISRG) has seen its share price rally by about 25% over the past three months, prompting a re-evaluation of its valuation. While a fair value narrative suggests it's 3.9% undervalued at $592.96 due to innovation and growth prospects, other metrics show it trading at a significantly higher PE ratio than its industry and peers. Investors need to weigh the strong growth story against potential valuation risks and intense competition.

**4. Groupe la Francaise Has $80.08 Million Stake in Intuitive Surgical, Inc. $ISRG**
- Source: MarketBeat | 20251203T050835 | Somewhat-Bullish | Relevance: 98%
-  Groupe la Francaise significantly increased its stake in Intuitive Surgical (NASDAQ:ISRG) by 99% in Q2, bringing its total holding to 147,161 shares valued at $80.08 million. This makes ISRG the firm's 20th largest holding. Despite this institutional accumulation, company insiders have been net sellers, offloading 86,804 shares worth approximately $48.04 million in the last 90 days.

**5. Intuitive Surgical (ISRG) Declined Due to Managementâ€™s Cautious Commentary**
- Source: Yahoo Finance | 20251203T135200 | Neutral | Relevance: 98%
- Intuitive Surgical (ISRG) stock declined despite strong second-quarter results and raised guidance, primarily due to management's cautious commentary regarding the European capital expenditure environment and conservative forward margin guidance. Brown Advisory, an investment management company, highlighted ISRG in its third-quarter 2025 investor letter, noting the stock's performance relative to the benchmark. The company's shares gained 3.23% over the last 52 weeks but saw a modest decline after this cautious outlook.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 5 ($4.83M) |
| Sells | 10 ($1.12M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 35.6% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.4% (+0.8%)
- Blackrock Inc.: 8.8% (+0.1%)
- State Street Corpora: 4.3% (-0.1%)
- Price (T.Rowe) Assoc: 3.6% (-4.4%)
- Geode Capital Manage: 2.3% (+1.0%)

### Key Risks

1. Premium valuation (P/E 59x, PEG 2.8x) vulnerable to multiple compression.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.79 signals overvaluation risk, limited margin of safety. Forward P/E 59.1x stretched relative to 13% growth. Quality metrics strong (margin 29%). Balance sheet: strong liquidity (4.7x), low leverage (D/E 0.14). Insider buying signal ($4.8M), management confidence. Institutional flow bearish (4 selling vs 5 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $200.1B |
| Beta | 1.69 |
| 52W Range | $425.00 - $616.00 |
| Short Interest | 2.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.79 |
| Forward P/E | 59.1 |
| Current P/E | 66.7 |
| YoY Growth | 12.7% |
| EPS Direction | RISING |

### Technicals

MRS_10 improving modestly (+0.6% over 5 days). Below STRENGTH zone by 3.8pp (needs >3.0% for momentum thesis). MRS_5 turning positive (0.4%) - potential reversal signal. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram bearish (-2.46), momentum weakening.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.81% (CS: 47) | Neutral |
| RSI_14 | 63.5 | Neutral |
| MACD Histogram | -2.46 | Bearish |
| vs SMA20 | 1.017x | Above |
| vs SMA50 | 1.115x | Above |
| vs SMA200 | 1.131x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $575.34
- **Stop Loss:** $550.44 (4.3% risk)
- **Target:** $600.24 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 20
- **Position Value:** $11,506.80
- **Portfolio %:** 11.51%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite persisting. Mixed earnings signals with industrial weakness (John Deere) offset by consumer/tech strength, while institutional flows show selective positioning rather than broad risk-off. Fed meeting in 9 days provides near-term catalyst but current data suggests status quo maintenance.*

### Earnings

**Next:** 2026-01-22 (Est: $2.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.99 | $2.40 | +20.7% |
| 2025Q2 | $1.92 | $2.19 | +14.1% |
| 2025Q1 | $1.73 | $1.81 | +4.4% |
| 2024Q4 | $1.79 | $2.21 | +23.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*